Home › NDC Lookup › RxCUI directory › RxCUI 252931

Allopurinol 500 MG Injection — RxCUI 252931

Name: Allopurinol 500 MG Injection (RxCUI 252931)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 252931 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI252931

Official nameAllopurinol 500 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asallopurinol (as allopurinol sodium) 500 MG Injection; allopurinol sodium 500 MG Injection

FDA products mapped4

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Allopurinol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Allopurinol lowers uric acid. The tablets are used for gout, for high uric acid caused by cancer treatment, and for recurrent calcium oxalate kidney stones in certain adults. The I...
No. Flares can happen early as uric acid shifts, and it can take months to settle. Your doctor will likely suggest colchicine or an anti-inflammatory to help prevent them. Keep tak...
I got a gout flare after starting it. Should I stop?
Nausea, diarrhea and mild changes in liver tests are the most common. A skin rash is the one to take seriously. Stop the medicine and get medical help right away if a rash or aller...

📖 Read our full Allopurinol guide →

🕸️ Concept Web — How Allopurinol 500 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Allopurinol 500 MG Injection RxCUI 252931 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Allopurinol 519 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Aloprim 261446 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Allopurinol Injection 1721587 SCDF
- Allopurinol Injectable Product 1154940 SCDG
- Allopurinol Injection [Aloprim] 1721590 SBDF
- Aloprim Injectable Product 1168494 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Allopurinol 500 MG 1721586 SCDC
- Allopurinol 500 MG Injection [Aloprim] 261265 SBD
- Allopurinol 500 MG [Aloprim] 1721589 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Allopurinol 500 MG SCDC · 1721586
Allopurinol Injection SCDF · 1721587
Allopurinol Injectable Product SCDG · 1154940

Brand-Name Concepts

Allopurinol 500 MG Injection [Aloprim] SBD · 261265
Allopurinol 500 MG [Aloprim] SBDC · 1721589
Allopurinol Injection [Aloprim] SBDF · 1721590
Aloprim Injectable Product SBDG · 1168494
Aloprim BN · 261446

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 252931 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9533-01	1 VIAL in 1 BOX, UNIT-DOSE (0143-9533-01) / 25 mL in 1 VIAL	Allopurinol sodium	Hikma Pharmaceuticals USA Inc.	2004-09-01
65219-0380-30	1 VIAL, GLASS in 1 CARTON (65219-380-30) / 25 mL in 1 VIAL,...	Allopurinol	Fresenius Kabi USA, LLC	2022-03-14
67457-0187-50	1 VIAL, GLASS in 1 CARTON (67457-187-50) / 25 mL in 1 VIAL,...	Aloprim	Mylan Institutional LLC	2007-05-15
68083-0380-01	1 VIAL, GLASS in 1 CARTON (68083-380-01) / 25 mL in 1 VIAL,...	Allopurinol	Gland Pharma Limited	2022-01-26

Observed labelers: Fresenius Kabi USA, LLC (1) · Gland Pharma Limited (1) · Hikma Pharmaceuticals USA Inc. (1) · Mylan Institutional LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0206	Inj allopurinol sodium 1 mg	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.